Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-09

Clinical Trial Update: Comparison of the Effects of Aripiprazole and Risperidone on the Pattern of Brain Activation in Schizophrenic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing aripiprazole and risperidone on brain activation patterns in patients with schizophrenia, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)
  • RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Qualissima | Conditions: Schizophrenia, Undifferentiated Type | Phase 4 | Status: COMPLETED | Results posted: 2014-04-09